More recently developed Zif-Aflibercept (Eylea, Zaltrap, VEGF-Trap, a hybrid fusion protein of VEGFR-1 and VEGFR-2 binding domains) is used for metastatic colorectal cancer that is resistant to an oxaliplatin-containing regimen. Here, VEGFA is linked to metastatic colorectal cancer.